PIMA541942
Brodalumab Recombinant Human Monoclonal Antibody, Invitrogen™
Manufacturer: Thermo Scientific
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | PIMA541942-Each-of-1 | In Stock | ₹ 44,020.62 |
PIMA541942 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 44,020.62
GST (18%): ₹ 7,923.712
Total Price: ₹ 51,944.332
Antigen
Brodalumab
Classification
Recombinant Monoclonal
Conjugate
Unconjugated
Gene Alias
AMG827; KHK4827
Immunogen
Human IL17RA/CD217
Quantity
100 μg
Primary or Secondary
Primary
Content And Storage
-20° C, Avoid Freeze/Thaw Cycles
Form
Liquid
Target Molecule
Chemical
Applications
ELISA
Concentration
2.95 mg/mL
Formulation
PBS with no preservative; pH 7.4
Host Species
Human
Purification Method
Protein A
Regulatory Status
RUO
Target Species
Chemical
Product Type
Antibody
Isotype
IgG2 κ
Related Products
Description
- Endotoxin level < 0.01EU/μg by LAL method Use a manual defrost freezer and avoid repeated freeze thaw cycles
- Store at 2 to 8 °C for one week
- Store at -20 to -80 °C for twelve months from the date of receipt
- Brodalumab has been used in trials studying the treatment of Asthma, Psoriasis, Crohn's Disease, Psoriatic Arthritis, and Rheumatoid Arthritis
- Brodalumab was FDA approved in February, 2017 as Siliq for the treatment of moderate-to-severe plaque psoriasis.
Compare Similar Items
Show Difference
Antigen: Brodalumab
Classification: Recombinant Monoclonal
Conjugate: Unconjugated
Gene Alias: AMG827; KHK4827
Immunogen: Human IL17RA/CD217
Quantity: 100 μg
Primary or Secondary: Primary
Content And Storage: -20° C, Avoid Freeze/Thaw Cycles
Form: Liquid
Target Molecule: Chemical
Applications: ELISA
Concentration: 2.95 mg/mL
Formulation: PBS with no preservative; pH 7.4
Host Species: Human
Purification Method: Protein A
Regulatory Status: RUO
Target Species: Chemical
Product Type: Antibody
Isotype: IgG2 κ
Antigen:
Brodalumab
Classification:
Recombinant Monoclonal
Conjugate:
Unconjugated
Gene Alias:
AMG827; KHK4827
Immunogen:
Human IL17RA/CD217
Quantity:
100 μg
Primary or Secondary:
Primary
Content And Storage:
-20° C, Avoid Freeze/Thaw Cycles
Form:
Liquid
Target Molecule:
Chemical
Applications:
ELISA
Concentration:
2.95 mg/mL
Formulation:
PBS with no preservative; pH 7.4
Host Species:
Human
Purification Method:
Protein A
Regulatory Status:
RUO
Target Species:
Chemical
Product Type:
Antibody
Isotype:
IgG2 κ
Antigen: Ficlatuzumab
Classification: Recombinant Monoclonal
Conjugate: Unconjugated
Gene Alias: AV-299; SCH 900105
Immunogen: Human HGF
Quantity: 100 μg
Primary or Secondary: Primary
Content And Storage: -20° C, Avoid Freeze/Thaw Cycles
Form: Liquid
Target Molecule: Chemical
Applications: ELISA, SDS-Page
Concentration: 3.51 mg/mL
Formulation: PBS with no preservative; pH 7.5
Host Species: Human
Purification Method: Protein A
Regulatory Status: RUO
Target Species: Chemical
Product Type: Antibody
Isotype: IgG1 κ
Antigen:
Ficlatuzumab
Classification:
Recombinant Monoclonal
Conjugate:
Unconjugated
Gene Alias:
AV-299; SCH 900105
Immunogen:
Human HGF
Quantity:
100 μg
Primary or Secondary:
Primary
Content And Storage:
-20° C, Avoid Freeze/Thaw Cycles
Form:
Liquid
Target Molecule:
Chemical
Applications:
ELISA, SDS-Page
Concentration:
3.51 mg/mL
Formulation:
PBS with no preservative; pH 7.5
Host Species:
Human
Purification Method:
Protein A
Regulatory Status:
RUO
Target Species:
Chemical
Product Type:
Antibody
Isotype:
IgG1 κ
Antigen: Ixekizumab
Classification: Recombinant Monoclonal
Conjugate: Unconjugated
Gene Alias: LY2439821
Immunogen: Human IL17A
Quantity: 100 μg
Primary or Secondary: Primary
Content And Storage: -20° C, Avoid Freeze/Thaw Cycles
Form: Liquid
Target Molecule: Chemical
Applications: ELISA, SDS-Page
Concentration: 1.15 mg/mL
Formulation: PBS with no preservative; pH 7.4
Host Species: Human
Purification Method: Protein A
Regulatory Status: RUO
Target Species: Chemical
Product Type: Antibody
Isotype: IgG4 κ
Antigen:
Ixekizumab
Classification:
Recombinant Monoclonal
Conjugate:
Unconjugated
Gene Alias:
LY2439821
Immunogen:
Human IL17A
Quantity:
100 μg
Primary or Secondary:
Primary
Content And Storage:
-20° C, Avoid Freeze/Thaw Cycles
Form:
Liquid
Target Molecule:
Chemical
Applications:
ELISA, SDS-Page
Concentration:
1.15 mg/mL
Formulation:
PBS with no preservative; pH 7.4
Host Species:
Human
Purification Method:
Protein A
Regulatory Status:
RUO
Target Species:
Chemical
Product Type:
Antibody
Isotype:
IgG4 κ
Antigen: Narnatumab
Classification: Recombinant Monoclonal
Conjugate: Unconjugated
Gene Alias: IMC RON-8; RON8
Immunogen: Human MST1R/CD136
Quantity: 100 μg
Primary or Secondary: Primary
Content And Storage: -20° C, Avoid Freeze/Thaw Cycles
Form: Liquid
Target Molecule: Chemical
Applications: ELISA, SDS-Page
Concentration: 2.11 mg/mL
Formulation: PBS with no preservative; pH 7.4
Host Species: Human
Purification Method: Protein A
Regulatory Status: RUO
Target Species: Chemical
Product Type: Antibody
Isotype: IgG1 κ
Antigen:
Narnatumab
Classification:
Recombinant Monoclonal
Conjugate:
Unconjugated
Gene Alias:
IMC RON-8; RON8
Immunogen:
Human MST1R/CD136
Quantity:
100 μg
Primary or Secondary:
Primary
Content And Storage:
-20° C, Avoid Freeze/Thaw Cycles
Form:
Liquid
Target Molecule:
Chemical
Applications:
ELISA, SDS-Page
Concentration:
2.11 mg/mL
Formulation:
PBS with no preservative; pH 7.4
Host Species:
Human
Purification Method:
Protein A
Regulatory Status:
RUO
Target Species:
Chemical
Product Type:
Antibody
Isotype:
IgG1 κ